Legrand A B, Narayanan T K, Ryan U S, Aronstam R S, Catravas J D
Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta 30912-2300.
Biochem Pharmacol. 1989 Feb 1;38(3):423-30. doi: 10.1016/0006-2952(89)90381-x.
We studied the effects of adenosine and adenosine derivatives on adenylate cyclase activity in cultured endothelial cells from bovine pulmonary artery. Basal and stimulated enzyme activities were measured in membrane preparations using [alpha-32P]ATP as the substrate and chromatographic isolation of formed [32P]cAMP. Basal cyclase activity was 11 +/- 1 (mean +/- SEM) pmol/mg protein/min. Forskolin, 5'-guanylylimidodiphosphate (Gpp(NH)p) and (-)isoproterenol stimulated adenylate cyclase in a concentration-dependent manner, producing maximal stimulations of three, seven and four times the basal activity respectively. In the presence of adenosine deaminase, cyclohexyladenosine, an A1 agonist, had no effect on basal and forskolin- or Gpp(NH)p-stimulated activities, whereas 5'-(N-ethyl)-carboxamidoadenosine (NECA), an A2 agonist, had a small stimulatory effect (52% increase over basal). In the presence of IBMX, adenosine and two P-site agonists, 2',5'-dideoxyadenosine (DDA) and 2'-deoxyadenosine-3'-monophosphate (2'-deoxy-3'-AMP), inhibited forskolin (30 microM)-stimulated adenylate cyclase activity with an order of potency of 2'-deoxy-3'-AMP greater than DDA greater than adenosine. DDA and 2'-deoxy-3'-AMP were also able to inhibit cyclase activity stimulated by Gpp(NH)p (10(-5)M) or isoproterenol (10(-6)M) with the same order of potency. Only 2'-deoxy-3'-AMP inhibited the stimulated adenylate cyclase activity by more than 50% (IC50 = 19-32 microM). These findings indicate that (1) long-term cultured endothelial cells from bovine pulmonary artery express A2 and beta-adrenergic receptors which stimulate adenylate cyclase activity through Gs transducer proteins, and (2) the natural compound and P-site agonist, 2'-deoxy-3'-AMP, is a potent inhibitor, and possibly a natural regulator, of adenylate cyclase activity in this tissue.
我们研究了腺苷及腺苷衍生物对牛肺动脉培养内皮细胞中腺苷酸环化酶活性的影响。使用[α-32P]ATP作为底物,通过色谱法分离生成的[32P]cAMP,在膜制剂中测定基础和刺激后的酶活性。基础环化酶活性为11±1(平均值±标准误)pmol/mg蛋白/分钟。福斯可林、5'-鸟苷酰亚胺二磷酸(Gpp(NH)p)和(-)异丙肾上腺素以浓度依赖的方式刺激腺苷酸环化酶,分别产生比基础活性高三倍、七倍和四倍的最大刺激作用。在腺苷脱氨酶存在的情况下,A1激动剂环己基腺苷对基础及福斯可林或Gpp(NH)p刺激的活性无影响,而A2激动剂5'-(N-乙基)-羧酰胺腺苷(NECA)有轻微的刺激作用(比基础活性增加52%)。在异丁基甲基黄嘌呤(IBMX)存在的情况下,腺苷以及两种P位点激动剂2',5'-二脱氧腺苷(DDA)和2'-脱氧腺苷-3'-单磷酸(2'-脱氧-3'-AMP)抑制福斯可林(30μM)刺激的腺苷酸环化酶活性,其效力顺序为2'-脱氧-3'-AMP>DDA>腺苷。DDA和2'-脱氧-3'-AMP也能够以相同的效力顺序抑制Gpp(NH)p(10^(-5)M)或异丙肾上腺素(10^(-6)M)刺激的环化酶活性。只有2'-脱氧-3'-AMP能将刺激后的腺苷酸环化酶活性抑制超过50%(半数抑制浓度IC50 = 19 - 32μM)。这些发现表明:(1)长期培养的牛肺动脉内皮细胞表达A2和β-肾上腺素能受体,它们通过Gs转导蛋白刺激腺苷酸环化酶活性;(2)天然化合物及P位点激动剂2'-脱氧-3'-AMP是该组织中腺苷酸环化酶活性的强效抑制剂,可能还是天然调节剂。